|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
decreases expression |
EXP |
Methoxsalen results in decreased expression of ABCB11 mRNA; Methoxsalen results in decreased expression of ABCB11 protein |
CTD |
PMID:28552422 |
|
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
decreases activity multiple interactions increases expression |
ISO |
Methoxsalen results in decreased activity of ABCB1 protein [Methoxsalen results in decreased activity of ABCB1 protein] which results in decreased export of and results in increased abundance of Daunorubicin; Verapamil inhibits the reaction [[Methoxsalen results in decreased activity of ABCB1 protein] which results in decreased export of and results in increased abundance of Daunorubicin]; Verapamil inhibits the reaction [Methoxsalen results in decreased activity of ABCB1 protein] Methoxsalen results in increased expression of ABCB1 mRNA |
CTD |
PMID:29079042 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcb4 |
ATP binding cassette subfamily B member 4 |
decreases expression |
ISO EXP |
Methoxsalen results in decreased expression of ABCB4 mRNA Methoxsalen results in decreased expression of ABCB4 mRNA; Methoxsalen results in decreased expression of ABCB4 protein |
CTD |
PMID:28552422 |
|
NCBI chr 4:25,150,998...25,209,489
Ensembl chr 4:25,151,953...25,209,202
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
increases expression |
ISO |
Methoxsalen results in increased expression of ABCC1 mRNA |
CTD |
PMID:29079042 |
|
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
decreases expression decreases activity multiple interactions |
ISO |
Methoxsalen results in decreased expression of ABCC2 mRNA Methoxsalen results in decreased activity of ABCC2 protein [Methoxsalen results in decreased activity of ABCC2 protein] which results in decreased export of and results in increased abundance of Daunorubicin; Indomethacin inhibits the reaction [[Methoxsalen results in decreased activity of ABCC2 protein] which results in decreased export of and results in increased abundance of Daunorubicin]; Indomethacin inhibits the reaction [Methoxsalen results in decreased activity of ABCC2 protein] |
CTD |
PMID:29079042 |
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Abcc3 |
ATP binding cassette subfamily C member 3 |
increases expression |
EXP ISO |
Methoxsalen results in increased expression of ABCC3 mRNA Methoxsalen results in increased expression of ABCC3 protein |
CTD |
PMID:28552422 PMID:30419252 |
|
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
|
|
G |
Abcc4 |
ATP binding cassette subfamily C member 4 |
affects expression increases expression |
ISO |
Methoxsalen affects the expression of ABCC4 protein Methoxsalen results in increased expression of ABCC4 mRNA |
CTD |
PMID:22173200 |
|
NCBI chr15:95,541,186...95,774,898
Ensembl chr15:95,542,315...95,774,283
|
|
G |
Abcg2 |
ATP binding cassette subfamily G member 2 |
multiple interactions increases expression decreases activity |
ISO |
[Methoxsalen results in decreased activity of ABCG2 protein] which results in decreased export of and results in increased abundance of Mitoxantrone; Novobiocin inhibits the reaction [[Methoxsalen results in decreased activity of ABCG2 protein] which results in decreased export of and results in increased abundance of Mitoxantrone]; Novobiocin inhibits the reaction [Methoxsalen results in decreased activity of ABCG2 protein] Methoxsalen results in increased expression of ABCG2 mRNA |
CTD |
PMID:29079042 |
|
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
|
|
G |
Ahr |
aryl hydrocarbon receptor |
increases activity multiple interactions |
EXP ISO |
Methoxsalen results in increased activity of AHR protein Methoxsalen inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CYP1A1 enhancer]] |
CTD |
PMID:7702611 PMID:15670584 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Atm |
ATM serine/threonine kinase |
multiple interactions |
ISO |
Methoxsalen inhibits the reaction [aflatoxin G1 results in increased expression of ATM protein modified form] |
CTD |
PMID:23907605 |
|
NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
|
|
G |
Atr |
ATR serine/threonine kinase |
multiple interactions |
ISO |
Methoxsalen inhibits the reaction [aflatoxin G1 results in increased expression of ATR protein modified form] |
CTD |
PMID:23907605 |
|
NCBI chr 8:96,426,704...96,524,152
Ensembl chr 8:96,426,724...96,524,136
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression |
ISO |
Methoxsalen results in increased expression of BAX protein |
CTD |
PMID:22796345 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions decreases expression |
ISO |
Methoxsalen inhibits the reaction [Aflatoxin B1 results in decreased expression of BCL2 protein] Methoxsalen results in decreased expression of BCL2 protein |
CTD |
PMID:22743290 PMID:22796345 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bhlhe40 |
basic helix-loop-helix family, member e40 |
multiple interactions decreases expression decreases response to substance |
ISO |
BHLHE40 protein inhibits the reaction [Methoxsalen results in decreased expression of BIRC5 protein]; BHLHE40 protein inhibits the reaction [Methoxsalen results in increased activity of and results in decreased expression of CASP3 protein] Methoxsalen results in decreased expression of BHLHE40 mRNA; Methoxsalen results in decreased expression of BHLHE40 protein BHLHE40 protein results in decreased susceptibility to Methoxsalen |
CTD |
PMID:22796345 |
|
NCBI chr 4:141,618,453...141,624,154
Ensembl chr 4:141,618,476...141,624,774
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
multiple interactions decreases expression |
ISO |
BHLHE40 protein inhibits the reaction [Methoxsalen results in decreased expression of BIRC5 protein] |
CTD |
PMID:22796345 |
|
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Brca1 |
BRCA1, DNA repair associated |
multiple interactions |
ISO |
Methoxsalen inhibits the reaction [aflatoxin G1 results in increased expression of BRCA1 protein modified form] |
CTD |
PMID:23907605 |
|
NCBI chr10:86,417,441...86,477,762
Ensembl chr10:86,418,000...86,477,304
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
ISO |
BHLHE40 protein inhibits the reaction [Methoxsalen results in increased activity of and results in decreased expression of CASP3 protein]; Methoxsalen inhibits the reaction [Aflatoxin B1 results in increased cleavage of CASP3 protein]; Methoxsalen inhibits the reaction [aflatoxin G1 results in increased expression of CASP3 protein modified form]; Methoxsalen results in decreased expression of and results in increased activity of CASP3 protein |
CTD |
PMID:22743290 PMID:22796345 PMID:23907605 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
decreases expression |
ISO |
Methoxsalen results in decreased expression of CASP8 protein |
CTD |
PMID:22796345 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
decreases expression |
ISO |
Methoxsalen results in decreased expression of CASP9 protein |
CTD |
PMID:22796345 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
multiple interactions |
ISO |
Methoxsalen inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CDKN1B protein] |
CTD |
PMID:15157999 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Ces2h |
carboxylesterase 2H |
multiple interactions increases expression |
ISO |
Dichlororibofuranosylbenzimidazole inhibits the reaction [Methoxsalen results in increased expression of CES2 mRNA]; NR1I2 protein promotes the reaction [Methoxsalen results in increased expression of CES2 mRNA] Methoxsalen results in increased expression of CES2 mRNA; Methoxsalen results in increased expression of CES2 protein |
CTD |
PMID:17003103 |
|
NCBI chr19:32,974,242...32,988,842
Ensembl chr19:32,974,242...32,988,830
|
|
G |
Chek2 |
checkpoint kinase 2 |
multiple interactions |
ISO |
Methoxsalen inhibits the reaction [aflatoxin G1 results in increased expression of CHEK2 protein modified form] |
CTD |
PMID:23907605 |
|
NCBI chr12:45,788,823...45,821,382
Ensembl chr12:45,788,827...45,821,286
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions decreases activity increases expression |
ISO EXP |
Methoxsalen inhibits the reaction [Carbaryl results in increased expression of CYP1A1 mRNA] Methoxsalen results in decreased activity of CYP1A1 protein Methoxsalen inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CYP1A1 enhancer]]; Methoxsalen inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1A1 protein]; Methoxsalen inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA] Methoxsalen results in increased expression of CYP1A1 mRNA Methoxsalen results in increased expression of and results in decreased activity of CYP1A1 protein |
CTD |
PMID:7702611 PMID:9169082 PMID:15670584 PMID:18420780 PMID:33814510 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
decreases activity |
EXP ISO |
Methoxsalen results in decreased activity of CYP1A2 protein |
CTD |
PMID:8819299 PMID:12814958 PMID:15879494 PMID:18420780 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
decreases activity |
ISO |
Methoxsalen results in decreased activity of CYP1B1 protein |
CTD |
PMID:18420780 PMID:33814510 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Cyp27a1 |
cytochrome P450, family 27, subfamily a, polypeptide 1 |
decreases expression |
EXP |
Methoxsalen results in decreased expression of CYP27A1 mRNA |
CTD |
PMID:28552422 |
|
NCBI chr 9:76,264,655...76,294,551
Ensembl chr 9:76,264,860...76,294,551
|
|
G |
Cyp2a1 |
cytochrome P450, family 2, subfamily a, polypeptide 1 |
decreases activity multiple interactions |
EXP ISO |
Methoxsalen results in decreased activity of CYP2A1 protein [Methoxsalen results in decreased activity of CYP2A13 protein] which results in decreased susceptibility to Skatole; Methoxsalen inhibits the reaction [CYP2A13 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone]; Methoxsalen inhibits the reaction [CYP2A13 protein results in increased metabolism of and results in increased activity of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone]; Methoxsalen inhibits the reaction [CYP2A13 protein results in increased susceptibility to Aflatoxin B1] |
CTD |
PMID:12814958 PMID:17671098 PMID:18669584 PMID:20795680 PMID:22743290 |
|
NCBI chr 1:82,231,611...82,244,887
Ensembl chr 1:82,231,611...82,244,887
|
|
G |
Cyp2a3 |
cytochrome P450, family 2, subfamily a, polypeptide 3 |
decreases activity |
EXP ISO |
Methoxsalen results in decreased activity of CYP2A3 protein Methoxsalen results in decreased activity of CYP2A4 protein |
CTD |
PMID:15879494 PMID:18420780 |
|
NCBI chr 1:82,171,914...82,179,980
Ensembl chr 1:82,169,949...82,179,979
|
|
G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
decreases activity |
EXP ISO |
Methoxsalen results in decreased activity of CYP2B1 protein Methoxsalen results in decreased activity of CYP2B10 protein |
CTD |
PMID:15879494 PMID:18420780 |
|
NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
|
|
G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
decreases activity |
EXP ISO |
Methoxsalen results in decreased activity of CYP2C11 protein Methoxsalen results in decreased activity of CYP2C9 protein |
CTD |
PMID:12814958 PMID:15879494 PMID:18420780 |
|
NCBI chr 1:236,762,719...236,799,069
Ensembl chr 1:236,762,842...236,799,066
|
|
G |
Cyp2c6v1 |
cytochrome P450, family 2, subfamily C, polypeptide 6, variant 1 |
decreases activity |
EXP |
Methoxsalen results in decreased activity of CYP2C6V1 protein |
CTD |
PMID:12814958 PMID:15879494 |
|
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
|
|
G |
Cyp2c79 |
cytochrome P450, family 2, subfamily c, polypeptide 79 |
decreases activity |
ISO |
Methoxsalen results in decreased activity of CYP2C29 protein |
CTD |
PMID:18420780 |
|
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
decreases activity |
ISO |
Methoxsalen results in decreased activity of CYP2D6 protein |
CTD |
PMID:18420780 |
|
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
decreases activity |
EXP ISO |
Methoxsalen results in decreased activity of CYP2E1 protein |
CTD |
PMID:15879494 PMID:18420780 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
decreases activity increases expression multiple interactions |
EXP ISO |
Methoxsalen results in decreased activity of CYP3A2 protein Methoxsalen results in increased expression of CYP3A4 mRNA; Methoxsalen results in increased expression of CYP3A4 protein Methoxsalen results in decreased activity of CYP3A4 protein Dichlororibofuranosylbenzimidazole inhibits the reaction [Methoxsalen results in increased expression of CYP3A4 mRNA]; NR1I2 protein promotes the reaction [Methoxsalen results in increased expression of CYP3A4 mRNA] |
CTD |
PMID:15879494 PMID:17003103 PMID:18420780 |
|
NCBI chr12:9,207,986...9,230,038
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp3a23-3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1 |
decreases activity |
EXP |
Methoxsalen results in decreased activity of CYP3A23-3A1 protein |
CTD |
PMID:15879494 |
|
NCBI chr12:9,256,159...9,285,020
Ensembl chr12:9,254,475...9,285,030
|
|
G |
Cyp7a1 |
cytochrome P450 family 7 subfamily A member 1 |
decreases expression multiple interactions increases expression |
EXP ISO |
Methoxsalen results in decreased expression of CYP7A1 mRNA Methoxsalen results in decreased expression of CYP7A1 protein Methoxsalen affects the reaction [VDR protein affects the expression of CYP7A1 protein] Methoxsalen results in increased expression of CYP7A1 protein |
CTD |
PMID:28552422 PMID:30419252 |
|
NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688
|
|
G |
Cyp8b1 |
cytochrome P450 family 8 subfamily B member 1 |
decreases expression |
EXP |
Methoxsalen results in decreased expression of CYP8B1 mRNA |
CTD |
PMID:28552422 |
|
NCBI chr 8:121,578,123...121,580,093
Ensembl chr 8:121,557,062...121,580,166
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
increases expression |
EXP |
Methoxsalen results in increased expression of GPT protein |
CTD |
PMID:28552422 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
H2ax |
H2A.X variant histone |
multiple interactions |
ISO |
Methoxsalen inhibits the reaction [aflatoxin G1 results in increased expression of H2AX protein modified form] |
CTD |
PMID:23907605 |
|
NCBI chr 8:44,671,927...44,673,257
Ensembl chr 8:44,671,786...44,673,239
|
|
G |
Hal |
histidine ammonia lyase |
decreases activity |
ISO |
Methoxsalen results in decreased activity of HAL protein |
CTD |
PMID:20880231 |
|
NCBI chr 7:28,007,449...28,037,701
Ensembl chr 7:28,006,972...28,037,701
|
|
G |
Nr0b2 |
nuclear receptor subfamily 0, group B, member 2 |
decreases expression multiple interactions increases expression |
EXP ISO |
Methoxsalen results in decreased expression of NR0B2 mRNA VDR protein affects the reaction [Methoxsalen results in increased expression of NR0B2 protein] |
CTD |
PMID:28552422 PMID:30419252 |
|
NCBI chr 5:145,779,294...145,782,609
Ensembl chr 5:145,779,294...145,782,609
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
decreases expression |
EXP |
Methoxsalen results in decreased expression of NR1H4 mRNA; Methoxsalen results in decreased expression of NR1H4 protein |
CTD |
PMID:28552422 |
|
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
multiple interactions increases activity |
ISO EXP |
NR1I2 protein promotes the reaction [Methoxsalen results in increased expression of CES2 mRNA]; NR1I2 protein promotes the reaction [Methoxsalen results in increased expression of CYP3A4 mRNA] Methoxsalen results in increased activity of NR1I2 protein |
CTD |
PMID:17003103 PMID:25455453 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions |
ISO |
Methoxsalen inhibits the reaction [Aflatoxin B1 results in increased expression of PARP1 protein modified form] |
CTD |
PMID:22743290 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
decreases expression |
EXP |
Methoxsalen results in decreased expression of PPARA mRNA; Methoxsalen results in decreased expression of PPARA protein |
CTD |
PMID:28552422 |
|
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
multiple interactions |
ISO |
Methoxsalen inhibits the reaction [Tetrachlorodibenzodioxin results in decreased phosphorylation of RB1 protein] |
CTD |
PMID:15157999 |
|
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
|
|
G |
Slc10a1 |
solute carrier family 10 member 1 |
decreases expression |
EXP |
Methoxsalen results in decreased expression of SLC10A1 mRNA; Methoxsalen results in decreased expression of SLC10A1 protein |
CTD |
PMID:28552422 |
|
NCBI chr 6:100,613,045...100,626,670
Ensembl chr 6:100,613,045...100,626,670
|
|
G |
Slc22a1 |
solute carrier family 22 member 1 |
increases expression |
ISO |
Methoxsalen results in increased expression of SLC22A1 protein |
CTD |
PMID:22173200 |
|
NCBI chr 1:48,076,657...48,103,679
Ensembl chr 1:48,076,666...48,103,678
|
|
G |
Slc22a2 |
solute carrier family 22 member 2 |
decreases expression increases expression |
ISO |
Methoxsalen results in decreased expression of SLC22A2 mRNA Methoxsalen results in increased expression of SLC22A2 protein |
CTD |
PMID:22173200 |
|
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
|
|
G |
Slc22a5 |
solute carrier family 22 member 5 |
increases expression |
ISO |
Methoxsalen results in increased expression of SLC22A5 protein |
CTD |
PMID:22173200 |
|
NCBI chr10:38,008,303...38,035,474
Ensembl chr10:38,008,311...38,035,309
|
|
G |
Slc22a6 |
solute carrier family 22 member 6 |
decreases expression |
ISO |
Methoxsalen results in decreased expression of SLC22A6 protein |
CTD |
PMID:22173200 |
|
NCBI chr 1:205,522,579...205,531,179
Ensembl chr 1:205,522,729...205,531,173
|
|
G |
Slc22a8 |
solute carrier family 22 member 8 |
increases expression |
ISO |
Methoxsalen results in increased expression of SLC22A8 protein |
CTD |
PMID:22173200 |
|
NCBI chr 1:205,496,331...205,516,378
Ensembl chr 1:205,498,084...205,517,450
|
|
G |
Slc2a9 |
solute carrier family 2 member 9 |
decreases expression increases expression |
ISO |
Methoxsalen results in decreased expression of SLC2A9 protein Methoxsalen results in increased expression of SLC2A9 mRNA |
CTD |
PMID:22173200 |
|
NCBI chr14:72,328,334...72,461,981
Ensembl chr14:72,328,320...72,461,981
|
|
G |
Tnf |
tumor necrosis factor |
decreases expression |
ISO |
Methoxsalen analog results in decreased expression of TNF protein |
CTD |
PMID:15052360 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tp53 |
tumor protein p53 |
increases expression multiple interactions |
ISO |
Methoxsalen results in increased expression of TP53 protein Methoxsalen inhibits the reaction [aflatoxin G1 results in increased expression of TP53 protein modified form] |
CTD |
PMID:22796345 PMID:23907605 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Vdr |
vitamin D receptor |
multiple interactions increases expression |
ISO |
Methoxsalen affects the reaction [VDR protein affects the expression of CYP7A1 protein]; VDR protein affects the reaction [Methoxsalen results in increased expression of NR0B2 protein] Methoxsalen results in increased expression of VDR protein |
CTD |
PMID:30419252 |
|
NCBI chr 7:128,987,981...129,037,677
Ensembl chr 7:128,987,981...129,037,677
|
|